Product
TJO-083
1 clinical trial
2 indications
Indication
Dry EyeIndication
Dry Eye SyndromeClinical trial
A Multi-center, Randomized, Double-blinded, Active Control, Parallel, Phase 3 Trial to Evaluate the Efficacy and Safety of TJO-083 in Dry Eye Diseases PatientsStatus: Recruiting, Estimated PCD: 2024-12-31